Clinical trial
Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally…
NCT00251329 · Cancer Research Network, Other · Unknown status
Key facts
| NCT number | NCT00251329 |
|---|---|
| Title | Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery |
| Official title | Phase II Neoadjuvant Trial of Docetaxel (Taxotere), Carboplatin, and Capecitabine (Xeloda) in the Treatment of Early Stage Locally Advanced and Inflammatory Breast Cancer |
| Lead sponsor | Cancer Research Network, Other |
| Collaborators | Sanofi Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | neoadjuvant chemotherapy |
| Enrollment | 48 |
| Start date | May 1, 2003 |
| First posted | Nov 10, 2005 |
| Last update posted | Apr 4, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: